En español
NIDA

Organizational Chart Description

2013 Organizational Structure

 

Office of the Director

Nora D. Volkow, M.D.
Director

David Shurtleff, Ph.D.
Acting Deputy Director

Glenda Conroy, MBA, CPA, PMP, CIA, CISA
Associate Director for Management

Office of Management

Glenda Conroy, MBA, CPA, PMP, CIA, CISA
Director

Office of Extramural Affairs

Teresa Levitin, Ph.D.
Director

Office of Science Policy and Communications

Susan Weiss, Ph.D.
Acting Director

Division of Clinical Neuroscience and Behavioral Research

Joseph Frascella, Ph.D.
Director

Division of Epidemiology, Services and Prevention Research

Wilson M. Compton, M.D., M.P.E.
Director

Intramural Research Program

Antonello Bonci, M.D.
Scientific Director

Center for the Clinical Trials Network

Betty Tai, Ph.D.
Director

Division of Basic Neurosciences and Behavioral Research

Joni Rutter, Ph.D.
Acting Director

Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Phil Skolnick, Ph.D., D.Sc.
Director

Go Back To: Fiscal Year 2013 Budget Information - Congressional Justification for National Institute on Drug Abuse